Femasys Inc (FEMY)

Nov 07, 2025

Femasys Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

Nov 07, 2025

Nov 07, 2025

Femasys Secures $12 Million Through Private Placement - TipRanks

Nov 07, 2025

Nov 07, 2025

[8-K] FEMASYS INC Reports Material Event | FEMY SEC FilingForm 8-K - Stock Titan

Nov 07, 2025

Nov 07, 2025

Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN

Nov 07, 2025

Nov 07, 2025

Why Femasys Inc. stock is considered a top pick2025 Market Sentiment & Safe Entry Zone Tips - newser.com

Nov 07, 2025

Nov 07, 2025

Combining machine learning predictions for Femasys Inc.Market Rally & Weekly Market Pulse Updates - newser.com

Nov 07, 2025

Nov 07, 2025

Can Femasys Inc. stock reach $100 price targetEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com

Nov 07, 2025

Nov 06, 2025

Is Femasys Inc. stock a safe haven assetEarnings Beat & AI Enhanced Trading Signals - newser.com

Nov 06, 2025

Nov 06, 2025

Is Femasys Inc. stock affected by interest rate hikesMarket Risk Summary & Daily Market Momentum Tracking - newser.com

Nov 06, 2025

Nov 06, 2025

What Wall Street predicts for Femasys Inc. stock price2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com

Nov 06, 2025

Nov 06, 2025

Applying Wyckoff theory to Femasys Inc. stockJuly 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com

Nov 06, 2025

Nov 06, 2025

Is Femasys Inc. trending in predictive chart modelsRate Hike & Verified Chart Pattern Signals - newser.com

Nov 06, 2025

Nov 06, 2025

Will Femasys Inc. stock continue upward momentumQuarterly Market Review & Community Consensus Trade Signals - newser.com

Nov 06, 2025

Nov 06, 2025

How resilient is Femasys Inc. stock in market downturns2025 Buyback Activity & Safe Capital Investment Plans - fcp.pa.gov.br

Nov 06, 2025

Nov 05, 2025

Applying Elliott Wave Theory to Femasys Inc.Take Profit & Fast Momentum Entry Tips - newser.com

Nov 05, 2025

Nov 05, 2025

Does Femasys Inc. show high probability of reboundJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com

Nov 05, 2025

Nov 05, 2025

How analysts rate Femasys Inc. stock todayJuly 2025 Trade Ideas & Verified Short-Term Plans - fcp.pa.gov.br

Nov 05, 2025

Nov 05, 2025

Exit strategy if you’re trapped in Femasys Inc.Weekly Loss Report & Consistent Return Strategy Ideas - newser.com

Nov 05, 2025

Nov 05, 2025

Is Femasys Inc. forming a bottoming baseQuarterly Growth Report & Expert Curated Trade Setups - newser.com

Nov 05, 2025

Nov 04, 2025

MSN Money - MSN

Nov 04, 2025

Nov 04, 2025

Femasys secures FDA approval to advance final FemBloc trial phase - MSN

Nov 04, 2025

Nov 04, 2025

Will Femasys Inc. stock benefit from commodity pricesEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

What margin trends mean for Femasys Inc. stockTrade Ideas & High Accuracy Swing Entry Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

What to do if you’re stuck in Femasys Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com

Nov 04, 2025

Nov 04, 2025

FDA approves Femasys to continue pivotal trial for non-surgical birth control - Investing.com Australia

Nov 04, 2025

Nov 04, 2025

Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - MSN

Nov 04, 2025

Nov 04, 2025

Femasys surges on Fembloc FDA approval, $58 million funding news | Tap to know more | Inshorts - Inshorts

Nov 04, 2025

Nov 03, 2025

Femasys Secures Fda Approval to Advance Final Fembloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - MarketScreener

Nov 03, 2025

Nov 03, 2025

Femasys Inc. announced that it expects to receive $12 million in funding - MarketScreener

Nov 03, 2025

Nov 03, 2025

Femasys (FEMY) Skyrockets on Breakthrough Birth Control Trial News – Is This Women’s Health Innovator a Game-Changer? - ts2.tech

Nov 03, 2025

Nov 03, 2025

Femasys Receives FDA Approval for FemBloc Trial - TipRanks

Nov 03, 2025

Nov 03, 2025

Femasys Inc Secures FDA Approval for Final FemBloc Trial Phase - TradingView

Nov 03, 2025

Nov 03, 2025

Femasys Inc. Advances FemBloc Toward FDA Approval with Successful Trial Completion and $12 Million Financing - Quiver Quantitative

Nov 03, 2025

Nov 03, 2025

Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - The Manila Times

Nov 03, 2025

Nov 03, 2025

Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, ... - Caledonian Record

Nov 03, 2025

Nov 03, 2025

Femasys (NASDAQ: FEMY) to issue $12M notes; warrants lift total potential to $58M - Stock Titan

Nov 03, 2025

Nov 03, 2025

Femasys Meets Nasdaq Equity Requirement After Offering - MSN

Nov 03, 2025

Nov 03, 2025

Custom watchlist performance reports with Femasys Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com

Nov 03, 2025